ROTTINGHAUS SCOTT T. (Chief Medical Officer) sold 3.5% of their position (798.00 shares) of ENANTA PHARMACEUTICALS INC on the open market
Open‑market sale worth $11.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/5/2025ACC: 0002064832-25-000065
Officer· Chief Medical Officer
Since Feb 2026
-798.00
Net shares
Net seller
$11.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
798.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−798.00
Price / share
$14.23
Trade value
$11.36K
% of position
3.5%
12/5/2025
22.59K→21.79K
Total
Net shares
−798.00
Net value
-$11.36K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/5/2025 | S · Sale | −798.00 | $14.23 | $11.36K | 3.5% | 22.59K | 21.79K |
| Total | −798.00 | -$11.36K | ||||||
Derivative Transactions0
No derivative transactions reported